https://www.thebodypro.com/collection/idweek-2020
patient with COVID-19
Conference Coverage

HIV Status Does Not Affect COVID-19 Hospitalization, Short-Term Outcomes in Connecticut Hospital

The findings add to a growing body of research showing that it’s other co-morbidities, not HIV, that lead to worse health outcomes from COVID-19—at least among individuals who are on stable antiretroviral therapy.

By Larry Buhl

Featured

pain
Interviews

How Can We Manage Pain Better in Older Adults Living With HIV?

“Telling them now that ‘the government is saying I need to decrease your opioids. ... Sorry you’re going to suffer,’ was just not satisfying to me as a physician,” says Maile Young Karris, M.D.

By Terri Wilder, M.S.W.
groceries
Conference Coverage

HIV Incidence Is Lower in States With More Generous Low-Income Food Benefits

“The message that needs to be communicated to people in power, and it needs to be communicated loud and frequently, is, ‘Look. Here’s the actual human cost of not enacting these kinds of policies. Here’s the potential benefit,’” says Aaron Richterman, M.D., M.P.H.

By Terri Wilder, M.S.W.
chlamydia
Conference Coverage

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

A recent expert debate explored the pros and cons of prescribing the antibiotic as a preventive measure for a subset of people at especially high risk for sexually transmitted infections.

By Michael Broder
birds on soil
Interviews

Histoplasmosis and HIV in the U.S.: Often Forgotten, Never Gone

IDWeek 2020 provided a perfect opportunity to better understand the modern-day impact of histoplasmosis among Americans living with HIV—and to bone up on the basics.

By Terri Wilder, M.S.W.
doctor talking to unrecognizable patient
Conference Coverage

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.

By Terri Wilder, M.S.W.
Homeless Man Shaking a Person's Hand
Conference Coverage

U.S. Homeless Shelters Are Key Centers for HIV and Tuberculosis Prevention, Experts Say

HIV and TB often go hand in hand among people experiencing homelessness in the U.S.—a reality that gives public health officials an opportunity to utilize shelters in tackling both viruses at the same time.

By Larry Buhl
injection
Conference Coverage

Long-Acting Injectable HIV Treatment Still Appears Safe and Effective—and Largely Accessible Despite COVID-19 Disruptions

Research newly presented at the IDWeek 2020 conference yields further promising data on injectable cabotegravir/rilpivirine, as well as encouraging info regarding COVID-19 disruptions in treatment delivery.

By Larry Buhl
scale and tape measure
Conference Coverage

Flurry of New Research Explores Weight Gain on Integrase Inhibitors Among People Living With HIV

Taken together, these studies appear to confirm that weight gain is a class effect of INSTIs, albeit with potential differences between individual drugs—and much left to be learned about the health impact.

By Michael Broder
medical scale
Conference Coverage

More Research Points to Weight Increases on TAF-Containing HIV Treatment

Although the mechanism and long-term implications remain unclear, these studies affirm that the effect is occurring—and that a person’s prior HIV treatment regimen may play a role.

By Michael Broder
Black man talking with his doctor in office.
Conference Coverage

B/F/TAF Holds Up as Switch Regimen for Black People Living With HIV, Including Those With Resistance

While the most striking aspect of the study was its demographic focus, the baseline resistance profile of the participants was also key.

By Michael Broder